Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy can cause hair changes similar to alopecia areata, which might lead to misdiagnosis.

Hair loss in mice starts with immune cells damaging hair roots before it becomes visible.

Horizontal scalp biopsy sections are better for diagnosing alopecia areata, showing fewer hair follicles and more miniaturized hairs.

Dermoscopy shows that diffuse alopecia areata progresses through specific hair growth stages.

The Lexington LaserComb helped regrow hair in mice with a condition similar to human hair loss.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

Cyclosporine A slows down hair loss from chemotherapy in mice, while dexamethasone increases hair loss but speeds up regrowth.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Kerascalp hair serum was found to be safe and effective in improving hair growth and strength in people with mild to moderate hair loss.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Trichoscopy is good for diagnosing and monitoring hair and scalp problems in children but needs more research for certain conditions.

Systemic diseases can cause hair loss, which is often reversible with treatment.

The document concludes that different types of hair loss have specific treatments, and early diagnosis is crucial for preventing permanent hair loss.

Human hair follicle organ culture is a useful model for hair research with potential for studying hair biology and testing treatments.

To manage diffuse hair loss, identify the cause, improve nutrition, remove triggers, and use specific treatments like minoxidil or finasteride.

The main causes of diffuse hair loss in women are telogen effluvium and androgenetic alopecia, often related to stress and iron deficiency.

The conclusion is to use scalp cooling, gentle hair care, and treatments like minoxidil for managing hair loss from chemotherapy, and stresses the need for more research and collaboration in this area.

A hormone linked to collagen helps hair grow back in mice after chemotherapy, and may also prevent bone loss.

Sorafenib may cause hair loss in a way similar to alopecia areata.

Trichoscopy helped diagnose and treat a woman with two different types of hair loss.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

Many patients find hair loss from chemotherapy very distressing, and while treatments like minoxidil and scalp cooling may help, there is no sure way to prevent it.

Recognizing the different stages of alopecia areata is crucial for accurate diagnosis and treatment.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Chemotherapy caused hair loss with specific patterns, but most patients had hair regrowth after treatment, while some had lasting hair loss.

The study suggests computer-assisted analysis of scalp biopsies could improve hair loss diagnosis but needs more validation.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.